Live Breaking News & Updates on Complera Eviplera

Stay updated with breaking news from Complera eviplera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Schroder Investment Management Group Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Schroder Investment Management Group raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 8.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,646,589 shares of the biopharmaceutical company’s stock after buying an additional 132,679 shares during the period. Schroder Investment Management Group’s holdings in Gilead Sciences were worth $133,390,000 as […] ....

United States , Complera Eviplera , Merdad Parsey , Fortitude Family Office , Holdings Channel , Wealth Management Group , Gilead Sciences Profile , Gilead Sciences Inc , Schroder Investment Management Group , Tompkins Financial Corp , News Ratings For Gilead Sciences Daily , Quarter For Gilead Sciences , Gilead Sciences , Gilead Sciences Stock Performance , Securities Exchange Commission , Gilead Sciences Announces Dividend , Needham Company , Wells Fargo Company , Rakuten Securities Inc , Free Report , Investment Management Group , Financial Corp , Family Office , Rakuten Securities , Get Free Report , Exchange Commission ,

Cibc World Markets Corp Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Cibc World Markets Corp cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 11.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 453,247 shares of the biopharmaceutical company’s stock after selling 58,865 shares during the quarter. Cibc World Markets Corp’s […] ....

United States , Merdad Parsey , Complera Eviplera , Wells Fargo Company , Norges Bank , Morgan Stanley , Gilead Sciences Company Profile , Gilead Sciences , Gilead Sciences Stock Performance , Manufacturers Life Insurance Company , News Ratings For Gilead Sciences Daily , Needham Company , Quarter For Gilead Sciences , Gilead Sciences Inc , Capital Research Global Investors , Clearbridge Investments , Cibc World Markets Corp , Gilead Sciences Announces Dividend , Securities Exchange Commission , Free Report , World Markets Corp , Research Global Investors , Get Free Report , Exchange Commission , Visit Holdingschannel , Gilead Sciences Daily ,

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Capital International Sarl

Capital International Sarl lifted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 19.4% in the fourth quarter, HoldingsChannel reports. The firm owned 69,414 shares of the biopharmaceutical company’s stock after buying an additional 11,255 shares during the period. Capital International Sarl’s holdings in Gilead Sciences were worth $5,623,000 at the end of […] ....

United States , Complera Eviplera , Merdad Parsey , Gilead Sciences Inc , Gilead Sciences , Quarter For Gilead Sciences , Capital International Sarl , News Ratings For Gilead Sciences Daily , Needham Company , Norges Bank , Gilead Sciences Dividend Announcement , Gilead Sciences Stock Performance , Gilead Sciences Company Profile , Manufacturers Life Insurance Company , International Assets Investment Management , Securities Exchange Commission , Clearbridge Investments , Free Report , International Sarl , Get Free Report , Exchange Commission , Visit Holdingschannel , Gilead Sciences Daily ,

Tower Research Capital LLC TRC Has $16.29 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […] ....

United States , Merdad Parsey , Complera Eviplera , Tower Research Capital , News Ratings For Gilead Sciences Daily , Gilead Sciences Announces Dividend , Wells Fargo Company , Gilead Sciences Company Profile , Gilead Sciences Inc , Maxim Group , Gilead Sciences , Hermes Inc , Gilead Sciences Price Performance , Wetzel Investment Advisors Inc , Charles Schwab Investment Management Inc , Quarter For Gilead Sciences , Altfest Lj Co , Free Report , Research Capital , Schwab Investment Management , Investment Advisors , Get Free Report , Visit Holdingschannel , Gilead Sciences Daily ,

Tower Research Capital LLC TRC Has $16.29 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […] ....

United States , Merdad Parsey , Complera Eviplera , Gilead Sciences Company Profile , Gilead Sciences Inc , Wells Fargo Company , Gilead Sciences Announces Dividend , News Ratings For Gilead Sciences Daily , Tower Research Capital , Quarter For Gilead Sciences , Altfest Lj Co , Wetzel Investment Advisors Inc , Charles Schwab Investment Management Inc , Gilead Sciences Price Performance , Hermes Inc , Maxim Group , Gilead Sciences , Free Report , Research Capital , Schwab Investment Management , Investment Advisors , Get Free Report , Visit Holdingschannel , Gilead Sciences Daily ,